Niche Focus Target opportunities in toxoplasmosis and other rare or serious diseases where Vyera demonstrates a focus on developing novel treatments, presenting potential for partnership in research collaborations, clinical trials, or co-development with specialty distributors.

Regulatory Spotlight Leverage Vyera's high-profile regulatory history and ongoing compliance scrutiny to position services around FDA/FTC liaison support, legal risk assessment, and market access strategies that help mitigate similar challenges for partners.

Pricing & Access Identify opportunities to offer value through pricing strategy advisory, payer negotiations, and access programs given Vyera's history of premium pricing and anticompetitive scrutiny, focusing on sustainable market access solutions.

Digital & IT Engage on technology platforms and digital ops improvements (AWS, Azure, SAP Concur, Paylocity, Nginx) to streamline operations, data analytics, and vendor management, offering integration or managed services that enhance efficiency for a small biotech-scale company.

Strategic Partnerships Propose collaboration opportunities with manufacturers or biotech firms seeking niche infectious disease programs, leveraging Vyera’s alumna status from Turing Pharmaceuticals to explore asset acquisition, licensing deals, or joint development in rare diseases.